213 related articles for article (PubMed ID: 8215640)
1. Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta production.
Chavin KD; Qin L; Lin J; Woodward JE; Baliga P; Bromberg JS
Ann Surg; 1993 Oct; 218(4):492-501; discussion 501-3. PubMed ID: 8215640
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
Transplantation; 1993 Apr; 55(4):901-8. PubMed ID: 8097344
[TBL] [Abstract][Full Text] [Related]
3. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
Chavin KD; Qin L; Lin J; Yagita H; Bromberg JS
J Immunol; 1993 Dec; 151(12):7249-59. PubMed ID: 7903105
[TBL] [Abstract][Full Text] [Related]
4. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement.
Punch JD; Tono T; Qin L; Bishop DK; Bromberg JS
J Immunol; 1998 Aug; 161(3):1156-62. PubMed ID: 9686574
[TBL] [Abstract][Full Text] [Related]
5. Induction of specific tolerance to allografts in rats by therapy with non-mitogenic, non-depleting anti-CD3 monoclonal antibody: association with TH2 cytokines not anergy.
Plain KM; Chen J; Merten S; He XY; Hall BM
Transplantation; 1999 Feb; 67(4):605-13. PubMed ID: 10071035
[TBL] [Abstract][Full Text] [Related]
6. Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance.
Chavin KD; Qin L; Woodward JE; Lin J; Bromberg JS
Transplantation; 1994 Mar; 57(5):736-40. PubMed ID: 7511258
[TBL] [Abstract][Full Text] [Related]
7. Transferrin receptor in T cell activation and transplantation.
Bayer AL; Baliga P; Woodward JE
J Leukoc Biol; 1998 Jul; 64(1):19-24. PubMed ID: 9665270
[TBL] [Abstract][Full Text] [Related]
8. Linked unresponsiveness: early cytokine gene expression profiles in cardiac allografts following pretreatment of recipients with bone marrow cells expressing donor MHC alloantigen.
Spriewald BM; Billing JS; Ensminger SM; Morris PJ; Wood KJ
Cytokine; 2002 Jul; 19(1):6-13. PubMed ID: 12200107
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival.
Qin L; Chavin KD; Lin J; Yagita H; Bromberg JS
J Exp Med; 1994 Jan; 179(1):341-6. PubMed ID: 7903681
[TBL] [Abstract][Full Text] [Related]
10. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression.
Lin J; Gettys TW; Qin L; Chavin KD; Yang Q; Ding Y; Punch JD; Bromberg JS
Pathobiology; 1995; 63(4):175-87. PubMed ID: 8866788
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD2 monoclonal antibody-induced receptor changes. II. Interaction of CD2 and CD3.
Lin J; Chavin KD; Qin L; Ding Y; Bromberg JS
Cell Immunol; 1996 Feb; 167(2):249-58. PubMed ID: 8603434
[TBL] [Abstract][Full Text] [Related]
12. Real-time polymerase chain reaction analysis reveals an evolution of cytokine mRNA production in allograft acceptor mice.
Xia D; Sanders A; Shah M; Bickerstaff A; Orosz C
Transplantation; 2001 Sep; 72(5):907-14. PubMed ID: 11571458
[TBL] [Abstract][Full Text] [Related]
13. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts.
Wei RQ; Schwartz CF; Lin H; Chen GH; Bolling SF
J Surg Res; 1999 Feb; 81(2):123-8. PubMed ID: 9927530
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production.
Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
Transplant Proc; 1993 Feb; 25(1 Pt 1):823-4. PubMed ID: 8094913
[No Abstract] [Full Text] [Related]
15. CD2-CD48 interactions promote cytotoxic T lymphocyte induction and function: anti-CD2 and anti-CD48 antibodies impair cytokine synthesis, proliferation, target recognition/adhesion, and cytotoxicity.
Musgrave BL; Watson CL; Hoskin DW
J Interferon Cytokine Res; 2003 Feb; 23(2):67-81. PubMed ID: 12744772
[TBL] [Abstract][Full Text] [Related]
16. Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection.
Räisänen-Sokolowski A; Mottram PL; Glysing-Jensen T; Satoskar A; Russell ME
J Clin Invest; 1997 Nov; 100(10):2449-56. PubMed ID: 9366559
[TBL] [Abstract][Full Text] [Related]
17. Acquisition of interleukin-5 secretion by human naive T-helper cells is regulated by distinct signals from both the T-cell receptor/CD3 complex and CD2.
Semnani RT; Svoboda K; Khoshnood B; van Seventer GA
Scand J Immunol; 1998 May; 47(5):436-43. PubMed ID: 9627127
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer for transplantation. Prolongation of allograft survival with transforming growth factor-beta 1.
Qin L; Chavin KD; Ding Y; Woodward JE; Favaro JP; Lin J; Bromberg JS
Ann Surg; 1994 Oct; 220(4):508-18; discussion 518-9. PubMed ID: 7944661
[TBL] [Abstract][Full Text] [Related]
19. CD3 and CD2 ligation alters CD49d epitope expression.
Lin J; Qin L; Chavin KD; Ding Y; Punch JD; Yang Q; Burkly LC; Bromberg JS
Pathobiology; 1995; 63(3):119-32. PubMed ID: 8821628
[TBL] [Abstract][Full Text] [Related]
20. Analysis of cytokine production and V beta T-cell receptor subsets in irradiated recipients receiving portal or peripheral venous reconstitution with allogeneic bone marrow cells, with or without additional anti-cytokine monoclonal antibodies.
Gorczynski RM; Chen Z; Zeng H; Gorczynski L; Terzioglu E
Immunology; 1998 Feb; 93(2):221-9. PubMed ID: 9616372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
